Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
Clinical advances and practice updates in genitourinary cancers: a 2024 review from the multidisciplinary Spanish 'Cambados annual meeting'.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Peláez Ignacio, Lázaro-Quintela Martín, Pérez-Fentes Daniel, Esteban-González Emilio, Gallardo Enrique, Álvarez-Fernández Carlos, Álvarez Rodríguez Pablo, Anido-Herranz Urbano, Azpitarte Raposeiras Cristina, Castro-Iglesias Ángel Maximino, Fernández Calvo Ovidio, Fernández Núñez Natalia, Folgar-Torres Alicia, García Lorenzo Carme, González-Del-Alba Aránzazu, Méndez-Vidal María José, Molina Díaz Aurea, Gómez Ignacio Rodríguez, Vázquez-Estévez Sergio
Аннотация
Prostate, bladder and kidney neoplasms are among the most prevalent genitourinary (GU) cancers worldwide. Significant therapeutic advancements in recent years have substantially improved patient outcomes. In response to this rapid progress, the Santiago de Compostela Health Research Institute (IDIS) has organized the annual 'Cambados Consensus Forum on Genitourinary Tumors' (Pontevedra, Spain) since 2018. This 2-day multidisciplinary meeting gathers Spanish medical oncologists, radiation oncologists, urologists, and hospital pharmacists to present and discuss the latest evidence in the field, merging from international congresses or journal publications. This review provides an overview of the most recent evidence regarding therapeutic advances in prostate cancer, renal cell carcinoma, and bladder cancer presented at the 2024 meeting (October), with a special focus on practice-changing innovations.